放化疗联合胸腔镜手术治疗Ⅲ期非小细胞肺癌的临床价值研究

Clinical Value of Radiotherapy Combined with Chemotherapy in the Treatment of Stage III Non Small Cell Lung Cancer

目的：探析手术为主的综合治疗运用在Ⅲ期非小细胞肺癌中的临床效果。方法：本组选择2010年3月至2011年3月期间收治的Ⅲ期非小细胞肺癌患者56例为研究对象，根据数字随机表法将其分为两组，其中给予对照细放化疗治疗，而观察组在胸腔镜手术治疗的基础上，联合放化疗治疗，比较两组治疗效果。结果：与对照捆比较，观察钼的治疗有效率较高，细间对比差异明显（p〈0.05）；两组不良反应发生率比较无明显差异（p〉0．05）；同时，随访1～5年，观察组的1年、3年以及5年生存率均较高，组间比较差异显著（p〈0．05）。结论：临床上给予Ⅲ期非小细胞肺癌患者手术为主的综合治疗，不仅可以降低不良反应发生率，还能提高远期生存率，值得推广。

Objective： To study the clinical effect of surgical treatment in patients with stage Ⅲ non-small cell lung canceer Method： The 2010 to March 2011 treated during March of stage Ⅲ non small cell lung cancer patients in 56 cases as the research object, according to the random number table method will be divided to two groups, compared two groups of treatment effect. Results： compared to the control group, between group differences significantly （P〈0.05）; two groups of incidence rate of adverse reaction had no significant difference （P〉0.05）; at the same time, followed up for 1-5 years observed group 1 year, 3 years and 5 years survival rates were higher in the, group significant difference （P〈0.05）. Conchtsion： The clinical treatment of patients with stage Ⅲ non-small cell Itmg cancer surgery mainly can not only reduce the incidence of adverse reactions, but also improve the long-term survival rate, it is worth promoting.